ArticleRegenerative biomaterials2026
Construction of hyperbranched polylysine-modified antibacterial polyurethane foam dressings and their promotion of infected deep burn wound healing.
Article in Regenerative biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foam dressings are vital for exuding wounds, yet antibacterial modification remains challenging and relies heavily on cytotoxic silver compounds. To address these challenges, in this study we developed a process for the antibacterial modification of polyurethane foam dressings using hyperbranched polylysine. The modification process consisted of a simple five-step procedure (soaking-drying-reacting-washing-drying) that did not compromise the foam's intrinsic properties, including hydrophilicity, pore structure and mechanical performance. The optimized modified foam achieved above 99.9% killing of both methicillin-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.